Table 2 Semiquantitative assessment of artifact reduction.
Corrected attenuation ± standard deviation | Hyperdense artifacts | Hypodense artifacts | Artifact impaired soft tissue |
---|---|---|---|
MDCT | |||
70 kVp | 2070.3 ± 595.0 | − 839.9 ± 140.0 | − 385.4 ± 198.4 |
80 kVp | 1157.5 ± 258.9 | − 807.7 ± 122.1 | − 174.0 ± 119.9 |
100 kVp | 944.2 ± 229.2 | − 498.7 ± 80.6 | − 105.4 ± 100.8 |
120 kVp | 713.1 ± 185.4 | − 359.4 ± 68.7 | − 94.7 ± 67.7 |
140 kVp | 641.5 ± 141.6 | − 286.4 ± 56.5 | − 59.2 ± 52.0 |
Sn 100 kVp | 326.4 ± 110.2 | − 161.7 ± 74.5 | − 58.2 ± 81.9 |
Sn 150 kVp | 216.1 ± 76.2 | − 85.9 ± 85.0 | − 40.0 ± 89.4 |
CBCT | |||
60 kVp | 941.0 ± 658.5 | 55.8 ± 271.2 | − 73.1 ± 170.9 |
80 kVp | 83.3 ± 93.6 | 73.8 ± 73.9 | − 2.5 ± 72.5 |
102 kVp | 73.2 ± 65.7 | 74.1 ± 59.9 | − 3.2 ± 62.5 |
117 kVp | 80.2 ± 53.2 | 73.8 ± 44.2 | − 5.1 ± 51.6 |
133 keV | 75.1 ± 52.8 | 75.2 ± 43.4 | − 2.0 ± 43.5 |
MDCT Sn 150 kVp | |||
vs. MDCT 70 kVp | < .001 | < .001 | < .001 |
vs. MDCT 80 kVp | .003 | < .001 | < .001 |
vs. MDCT 100 kVp | < .001 | < .001 | < .001 |
vs. MDCT 120 kVp | < .001 | < .001 | < .001 |
vs. MDCT 140 kVp | < .001 | < .001 | .029 |
vs. MDCT Sn 100 kVp | .034 | .023 | .216 |
vs. CBCT 60 kVp | .017 | .032 | .940 |
vs. CBCT 80 kVp | .036 | .008 | .001 |
vs. CBCT 102 kVp | .039 | .004 | < .001 |
vs. CBCT 117 kVp | .027 | .010 | < .001 |
vs. CBCT 133 kVp | .033 | .009 | < .001 |
CBCT 80 kVp | |||
vs. MDCT 70 kVp | < .001 | < .001 | < .001 |
vs. MDCT 80 kVp | .001 | < .001 | < .001 |
vs. MDCT 100 kVp | < .001 | < .001 | < .001 |
vs. MDCT 120 kVp | < .001 | < .001 | < .001 |
vs. MDCT 140 kVp | < .001 | < .001 | < .001 |
vs. MDCT Sn 100 kVp | .007 | < .001 | < .001 |
vs. MDCT Sn 150 kVp | .036 | .008 | .001 |
vs. CBCT 60 kVp | .006 | 1 | .156 |
vs. CBCT 102 kVp | .366 | 1 | 1 |
vs. CBCT 117 kVp | 1 | 1 | 1 |
vs. CBCT 133 kVp | .925 | 1 | 1 |